Medication info

Winapro Tablet (Irbesartan)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Hanwha Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 200703847 · Notified 2007.04.04

This product's status changed to Approval withdrawn on 2023.11.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Hanwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension

  • Essential hypertension
  • hypertension
  • nephropathy in type 2 diabetes patients
View approved original text

This medication is used for the treatment of essential hypertension and is particularly helpful in preventing and treating nephropathy in patients with type 2 diabetes associated with hypertension. It effectively controls high blood pressure, thereby reducing cardiovascular complications and protecting kidney function. Therefore, it is used in the management of essential hypertension and diabetes-related nephropathy.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This drug can cause severe harm to the fetus during pregnancy, so it must not be taken by women who are pregnant or may become pregnant. Additionally, it should not be used by patients with an allergic reaction to this drug, severe liver impairment, history of angioedema, or certain kidney diseases and diabetic nephropathy. Elderly patients, those with poor kidney function, or patients with hyperkalemia should use this drug cautiously, requiring regular blood tests and monitoring of physical conditions. This drug generally has many mild side effects, but serious side effects such as angioedema, hyperkalemia, renal failure, liver function impairment, hypoglycemia, and rhabdomyolysis can occur rarely, so any abnormal symptoms should prompt immediate consultation with healthcare providers. This drug can be combined with other antihypertensives to enhance blood pressure-lowering effects, but combinations with potassium-sparing diuretics, potassium supplements, and lithium preparations should be avoided. Care must be taken when using it with nonsteroidal anti-inflammatory drugs (NSAIDs) due to the risk of worsening kidney function. It is advisable for breastfeeding women to avoid this medication; if unavoidable, breastfeeding should be discontinued. Dizziness and fatigue may occur, so caution is advised when driving or operating machinery, and diabetic patients should be particularly alert to symptoms of hypoglycemia. In the case of overdose, hypotension and tachycardia may occur, necessitating immediate evaluation at a healthcare facility for appropriate treatment. Lastly, it is preferable not to use this drug in children since its safety and effectiveness have not been confirmed.

Side effects

  • Upper respiratory infection
  • sinus abnormalities
  • influenza
  • pharyngitis
  • rhinitis
  • musculoskeletal pain
  • myalgia
  • headache
  • dizziness
  • fatigue
Show 113 more
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal trauma
  • chest pain
  • dyspepsia
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flush
  • heart murmur
  • myocardial infarction
  • angina pectoris
  • arrhythmia
  • conduction abnormality
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • pruritus
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastritis
  • abdominal distension
  • limb edema
  • muscle stiffness
  • arthritis
  • muscle weakness
  • sleep disorders
  • paralysis
  • drowsiness
  • mood disorders
  • depression
  • sensory disturbances
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory disturbances
  • otitis
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • orthostatic dizziness
  • orthostatic hypotension
  • weakness
  • dyspepsia
  • tinnitus
  • increased plasma creatine kinase
  • arthralgia
  • hepatitis
  • liver dysfunction
  • renal failure
  • psoriasis
  • photosensitivity reactions
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • myalgia
  • malaise
  • elevated serum and urine myoglobin
  • palpitations
  • dyspnea
  • sensory hypoesthesia
  • hypertriglyceridemia
  • insomnia
  • taste disturbance
  • thirst
  • abdominal distension
  • oral bleeding
  • increased sputum
  • decreased HDL
  • increased salivation
  • surface
  • granulocytopenia
  • leukopenia
  • erectile dysfunction
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to keep it in a cool, dry place at or below 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.